


Searching News Database: nail fungus
HSMN NewsFeed - 9 Dec 2019
Moberg Pharma Meets Primary Endpoint for MOB-015 in a Phase 3 Study for the Treatment of Onychomycosis
Moberg Pharma Meets Primary Endpoint for MOB-015 in a Phase 3 Study for the Treatment of Onychomycosis
HSMN NewsFeed - 10 Apr 2012
Ellman International, Inc. Appoints Dave Pfeiffer as Chief Commercial Officer
Ellman International, Inc. Appoints Dave Pfeiffer as Chief Commercial Officer
HSMN NewsFeed - 20 Oct 2010
PinPointe FootLaser Receives FDA Clearance for the Treatment of Nail Fungus (Onychomycosis)
PinPointe FootLaser Receives FDA Clearance for the Treatment of Nail Fungus (Onychomycosis)
HSMN NewsFeed - 16 Dec 2009
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
HSMN NewsFeed - 25 Aug 2009
Medical Industry Veteran Bob Katz to Lead Newly Established PinPointe USA, Inc. as CEO
Medical Industry Veteran Bob Katz to Lead Newly Established PinPointe USA, Inc. as CEO
HSMN NewsFeed - 7 Jan 2009
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
HSMN NewsFeed - 3 Sep 2008
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
HSMN NewsFeed - 17 Apr 2007
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
HSMN NewsFeed - 31 Jan 2007
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
HSMN NewsFeed - 4 Dec 2006
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
HSMN NewsFeed - 27 Sep 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
Additional items found! 10
Members Archive contains
10 additional stories matching:
nail fungus
(Password required)
nail fungus
(Password required)
